TapewireFind a company

person · Reporting owner

Ross Bridget A

Disclosed activity across 2 companies

Tapewire entity
48403
SEC CIK
0001698518

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
HENRY SCHEIN INCHSIC · Entity 3536President, Global Medical GrpMarch 06, 2017March 08, 2017
LEMAITRE VASCULAR INCLMAT · Entity 1927DirectorMay 07, 2026May 11, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

HENRY SCHEIN INC

Report date March 06, 2017 · Filed March 08, 2017

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common Stock, par value $0.01 per shareSEC Table I · non-derivativeDirect9,654 Reported balance After 2017-03-06 transaction · row 1
1 source row

Row 1 · 2017-03-06 · Grant · Acquired 9,654 · Balance 9,654

F1: Grant of restricted stock (RS) pursuant to the Issuer's 2013 Stock Incentive Plan. Subject to certain exceptions, 65% will vest subject to (x) Issuer's achievement of a specified performance goal and (y) reporting person's continued perf. of services for the Issuer. 35% will vest subject to (x) passage of a specified period of time and (y) reporting person's continued perf. of services for the Issuer. With respect to the performance-based RS, if the continued service requirement is satisfied and achievement of the performance goal (x) exceeds 100% of target, the Issuer may issue additional vested shares of common stock in an amount that corresponds to the incremental percentage of the performance goal achieved in excess of 100% of target or (y) is less than 100% of target, the reporting person will surrender to the Issuer shares of common stock in an amount that corresponds to the incremental percentage of the performance goal achieved that is below 100% of target (i.e., shortfall).

Filing footnotes · ownership attribution and instrument terms

F1: Grant of restricted stock (RS) pursuant to the Issuer's 2013 Stock Incentive Plan. Subject to certain exceptions, 65% will vest subject to (x) Issuer's achievement of a specified performance goal and (y) reporting person's continued perf. of services for the Issuer. 35% will vest subject to (x) passage of a specified period of time and (y) reporting person's continued perf. of services for the Issuer. With respect to the performance-based RS, if the continued service requirement is satisfied and achievement of the performance goal (x) exceeds 100% of target, the Issuer may issue additional vested shares of common stock in an amount that corresponds to the incremental percentage of the performance goal achieved in excess of 100% of target or (y) is less than 100% of target, the reporting person will surrender to the Issuer shares of common stock in an amount that corresponds to the incremental percentage of the performance goal achieved that is below 100% of target (i.e., shortfall).

LEMAITRE VASCULAR INC

Report date May 07, 2026 · Filed May 11, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect3,942 Ending reported balance After 2026-05-07 transaction · row 3
3 source rows · reconciled sequence

Row 1 · 2026-05-07 · Exercise / conversion · Acquired 3,444 · Balance 7,386

F1: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II.

Row 2 · 2026-05-07 · Exercise / conversion · Acquired 1,600 · Balance 8,986

F1: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II.

Row 3 · 2026-05-07 · Sale · Disposed 5,044 · Balance 3,942

F2: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $111.00 to $111.30. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.

Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $48.60 · Expires 2026-12-11Direct0 Reported balance After 2026-05-07 transaction · row 4 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 4 · 2026-05-07 · Exercise / conversion · Disposed 3,444 · Balance 0

F3: This option is fully vested and exercisable.

Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $47.19 · Expires 2027-12-12Direct1,609 Reported balance After 2026-05-07 transaction · row 5 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 5 · 2026-05-07 · Exercise / conversion · Disposed 1,600 · Balance 1,609

F3: This option is fully vested and exercisable.

Filing footnotes · ownership attribution and instrument terms

F1: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II.

F2: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $111.00 to $111.30. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.

F3: This option is fully vested and exercisable.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
May 07, 2026 Filed May 11, 2026 21:10 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 Exercise / conversionStock Option (Right to Buy) · Derivative 1,600 $0.00 Strike: $47.19 $0.00
Disclosure

SEC source: 0001193125-26-217103 · ownership.xml · derivative · entry 5

Ross Bridget A · CIK 0001698518 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,609

Underlying: Common Stock · 1,600 shares

Expires 2027-12-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: This option is fully vested and exercisable.

Read SEC document
May 07, 2026 Filed May 11, 2026 21:10 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 Exercise / conversionStock Option (Right to Buy) · Derivative 3,444 $0.00 Strike: $48.60 $0.00
Disclosure

SEC source: 0001193125-26-217103 · ownership.xml · derivative · entry 4

Ross Bridget A · CIK 0001698518 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,444 shares

Expires 2026-12-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: This option is fully vested and exercisable.

Read SEC document
May 07, 2026 Filed May 11, 2026 21:10 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 SaleCommon Stock 5,044 $111.10 $560,366.21
Disclosure

SEC source: 0001193125-26-217103 · ownership.xml · nonDerivative · entry 3

Ross Bridget A · CIK 0001698518 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,942

F2 · price: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $111.00 to $111.30. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.

Read SEC document
May 07, 2026 Filed May 11, 2026 21:10 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 Exercise / conversionCommon Stock 1,600 $47.19 $75,504.00
Disclosure

SEC source: 0001193125-26-217103 · ownership.xml · nonDerivative · entry 2

Ross Bridget A · CIK 0001698518 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,986

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II.

Read SEC document
May 07, 2026 Filed May 11, 2026 21:10 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 Exercise / conversionCommon Stock 3,444 $48.60 $167,378.40
Disclosure

SEC source: 0001193125-26-217103 · ownership.xml · nonDerivative · entry 1

Ross Bridget A · CIK 0001698518 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,386

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II.

Read SEC document
March 26, 2026 Filed Mar 30, 2026 22:03 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantDividend Equivalent Rights · Derivative 1.2077 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-132310 · ownership.xml · derivative · entry 5

Ross Bridget A · CIK 0001698518 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1.2077

Underlying: Common Stock · 1.2077 shares

Expires not disclosed

F5 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F5 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F5 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
March 26, 2026 Filed Mar 30, 2026 22:03 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantDividend Equivalent Rights · Derivative 0.7276 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-132310 · ownership.xml · derivative · entry 4

Ross Bridget A · CIK 0001698518 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3.6239

Underlying: Common Stock · 0.7276 shares

Expires not disclosed

F4 · derivative.exercise_price: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F4 · derivative.exercise_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F4 · derivative.expiration_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
March 26, 2026 Filed Mar 30, 2026 22:03 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantDividend Equivalent Rights · Derivative 0.6426 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-132310 · ownership.xml · derivative · entry 3

Ross Bridget A · CIK 0001698518 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3.5389

Underlying: Common Stock · 0.6426 shares

Expires not disclosed

F3 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F3 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F3 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
March 26, 2026 Filed Mar 30, 2026 22:03 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantDividend Equivalent Rights · Derivative 0.472 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-132310 · ownership.xml · derivative · entry 2

Ross Bridget A · CIK 0001698518 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4.3113

Underlying: Common Stock · 0.472 shares

Expires not disclosed

F2 · derivative.exercise_price: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F2 · derivative.exercise_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F2 · derivative.expiration_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
March 26, 2026 Filed Mar 30, 2026 22:03 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantDividend Equivalent Rights · Derivative 0.3941 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-132310 · ownership.xml · derivative · entry 1

Ross Bridget A · CIK 0001698518 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4.6016

Underlying: Common Stock · 0.3941 shares

Expires not disclosed

F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
February 26, 2026 Filed Mar 3, 2026 02:12 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 Exercise / conversionDividend Equivalent Rights · Derivative 1 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-086311 · ownership.xml · derivative · entry 3

Ross Bridget A · CIK 0001698518 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2.8963

Underlying: Common Stock · 1 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a PSU award granted on December 6, 2024. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F3 · shares: These dividend equivalent rights were released in connection with the vesting of a PSU award granted on December 6, 2024. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F3 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a PSU award granted on December 6, 2024. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F3 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a PSU award granted on December 6, 2024. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
February 26, 2026 Filed Mar 3, 2026 02:12 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 Exercise / conversionCommon Stock 1 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-086311 · ownership.xml · nonDerivative · entry 2

Ross Bridget A · CIK 0001698518 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,942

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.

F2 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.

Read SEC document
February 26, 2026 Filed Mar 3, 2026 02:12 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantCommon Stock 476 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-086311 · ownership.xml · nonDerivative · entry 1

Ross Bridget A · CIK 0001698518 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,941

F1 · shares: These shares represent LMAT common stock acquired on February 26, 2026, upon settlement of a Performance Share Unit (PSU) award granted on December 6, 2024. The PSU award vested 1/3 upon determination of satisfaction of the performance condition (on 2/26/2026), and the balance vests in equal annual installments on the grant date anniversary over the next two years.

Read SEC document
December 12, 2025 Filed Dec 15, 2025 23:10 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 Exercise / conversionDividend Equivalent Rights · Derivative 5 $0.00 $0.00
Disclosure

SEC source: 0001193125-25-319545 · ownership.xml · derivative · entry 4

Ross Bridget A · CIK 0001698518 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a performance stock unit award granted on 12/12/2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F4 · shares: These dividend equivalent rights were released in connection with the vesting of a performance stock unit award granted on 12/12/2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F4 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a performance stock unit award granted on 12/12/2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F4 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a performance stock unit award granted on 12/12/2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F3 · balance_after: Fractional shares (if any) were settled in cash on each vesting date, resulting in a final balance of zero.

Read SEC document
December 12, 2025 Filed Dec 15, 2025 23:10 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 Exercise / conversionDividend Equivalent Rights · Derivative 5 $0.00 $0.00
Disclosure

SEC source: 0001193125-25-319545 · ownership.xml · derivative · entry 3

Ross Bridget A · CIK 0001698518 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/12/2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F2 · shares: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/12/2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F2 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/12/2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F2 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/12/2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F3 · balance_after: Fractional shares (if any) were settled in cash on each vesting date, resulting in a final balance of zero.

Read SEC document
December 12, 2025 Filed Dec 15, 2025 23:10 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 Exercise / conversionCommon Stock 5 $0.00 $0.00
Disclosure

SEC source: 0001193125-25-319545 · ownership.xml · nonDerivative · entry 2

Ross Bridget A · CIK 0001698518 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,465

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.

F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.

Read SEC document
December 12, 2025 Filed Dec 15, 2025 23:10 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 Exercise / conversionCommon Stock 5 $0.00 $0.00
Disclosure

SEC source: 0001193125-25-319545 · ownership.xml · nonDerivative · entry 1

Ross Bridget A · CIK 0001698518 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,460

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.

F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.

Read SEC document
December 10, 2025 Filed Dec 11, 2025 23:08 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantStock Option (Right to Buy) · Derivative 3,431 $0.00 Strike: $83.66 $0.00
Disclosure

SEC source: 0001193125-25-316343 · ownership.xml · derivative · entry 2

Ross Bridget A · CIK 0001698518 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,431

Underlying: Common Stock · 3,431 shares

Expires 2030-12-10

F2 · derivative.exercise_date: This option is exercisable and vests over a three-year period at a rate of 33 1/3% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining two years.

Read SEC document
December 10, 2025 Filed Dec 11, 2025 23:08 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantCommon Stock 533 $0.00 $0.00
Disclosure

SEC source: 0001193125-25-316343 · ownership.xml · nonDerivative · entry 1

Ross Bridget A · CIK 0001698518 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,455

F1 · shares: Represents a restricted stock unit award that vests on a time-based schedule as follows: 33 1/3% of the award vests on 12/1/2026, with the balance vesting in equal annual installments over the remaining two years.

Read SEC document
December 08, 2025 Filed Dec 11, 2025 00:26 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 Exercise / conversionDividend Equivalent Rights · Derivative 3 $0.00 $0.00
Disclosure

SEC source: 0001193125-25-314619 · ownership.xml · derivative · entry 4

Ross Bridget A · CIK 0001698518 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3.8393

Underlying: Common Stock · 3 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a performance stock unit award granted on 12/8/2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F3 · shares: These dividend equivalent rights were released in connection with the vesting of a performance stock unit award granted on 12/8/2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F3 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a performance stock unit award granted on 12/8/2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F3 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a performance stock unit award granted on 12/8/2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
December 08, 2025 Filed Dec 11, 2025 00:26 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 Exercise / conversionDividend Equivalent Rights · Derivative 2 $0.00 $0.00
Disclosure

SEC source: 0001193125-25-314619 · ownership.xml · derivative · entry 3

Ross Bridget A · CIK 0001698518 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4.2075

Underlying: Common Stock · 2 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/8/2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F2 · shares: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/8/2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F2 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/8/2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F2 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/8/2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
December 08, 2025 Filed Dec 11, 2025 00:26 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 Exercise / conversionCommon Stock 3 $0.00 $0.00
Disclosure

SEC source: 0001193125-25-314619 · ownership.xml · nonDerivative · entry 2

Ross Bridget A · CIK 0001698518 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,922

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.

F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.

Read SEC document
December 08, 2025 Filed Dec 11, 2025 00:26 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 Exercise / conversionCommon Stock 2 $0.00 $0.00
Disclosure

SEC source: 0001193125-25-314619 · ownership.xml · nonDerivative · entry 1

Ross Bridget A · CIK 0001698518 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,919

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.

F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.

Read SEC document
December 06, 2025 Filed Dec 9, 2025 01:20 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 Exercise / conversionDividend Equivalent Rights · Derivative 1 $0.00 $0.00
Disclosure

SEC source: 0001193125-25-311604 · ownership.xml · derivative · entry 7

Ross Bridget A · CIK 0001698518 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2.8963

Underlying: Common Stock · 1 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/6/2024. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F7 · shares: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/6/2024. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F7 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/6/2024. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F7 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/6/2024. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
December 06, 2025 Filed Dec 9, 2025 01:20 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 Exercise / conversionCommon Stock 1 $0.00 $0.00
Disclosure

SEC source: 0001193125-25-311604 · ownership.xml · nonDerivative · entry 1

Ross Bridget A · CIK 0001698518 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,917

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.

F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.

Read SEC document
December 04, 2025 Filed Dec 9, 2025 01:20 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantDividend Equivalent Rights · Derivative 0.9869 $0.00 $0.00
Disclosure

SEC source: 0001193125-25-311604 · ownership.xml · derivative · entry 6

Ross Bridget A · CIK 0001698518 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3.8963

Underlying: Common Stock · 0.9869 shares

Expires not disclosed

F6 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F6 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F6 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
December 04, 2025 Filed Dec 9, 2025 01:20 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantDividend Equivalent Rights · Derivative 0.9702 $0.00 $0.00
Disclosure

SEC source: 0001193125-25-311604 · ownership.xml · derivative · entry 5

Ross Bridget A · CIK 0001698518 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6.8393

Underlying: Common Stock · 0.9702 shares

Expires not disclosed

F5 · derivative.exercise_price: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F5 · derivative.exercise_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F5 · derivative.expiration_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
December 04, 2025 Filed Dec 9, 2025 01:20 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantDividend Equivalent Rights · Derivative 0.81 $0.00 $0.00
Disclosure

SEC source: 0001193125-25-311604 · ownership.xml · derivative · entry 4

Ross Bridget A · CIK 0001698518 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6.2075

Underlying: Common Stock · 0.81 shares

Expires not disclosed

F4 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F4 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F4 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
December 04, 2025 Filed Dec 9, 2025 01:20 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantDividend Equivalent Rights · Derivative 0.4736 $0.00 $0.00
Disclosure

SEC source: 0001193125-25-311604 · ownership.xml · derivative · entry 3

Ross Bridget A · CIK 0001698518 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6.0005

Underlying: Common Stock · 0.4736 shares

Expires not disclosed

F3 · derivative.exercise_price: These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F3 · derivative.exercise_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F3 · derivative.expiration_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
December 04, 2025 Filed Dec 9, 2025 01:20 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantDividend Equivalent Rights · Derivative 0.4736 $0.00 $0.00
Disclosure

SEC source: 0001193125-25-311604 · ownership.xml · derivative · entry 2

Ross Bridget A · CIK 0001698518 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6.9892

Underlying: Common Stock · 0.4736 shares

Expires not disclosed

F2 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F2 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F2 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
September 04, 2025 Filed Sep 8, 2025 22:28 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantDividend Equivalent Rights · Derivative 0.8697 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-028586 · rdgdoc.xml · derivative · entry 5

Ross Bridget A · CIK 0001698518 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2.9094

Underlying: Common Stock · 0.8697 shares

Expires not disclosed

F5 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F5 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F5 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
September 04, 2025 Filed Sep 8, 2025 22:28 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantDividend Equivalent Rights · Derivative 0.8546 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-028586 · rdgdoc.xml · derivative · entry 4

Ross Bridget A · CIK 0001698518 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5.8691

Underlying: Common Stock · 0.8546 shares

Expires not disclosed

F4 · derivative.exercise_price: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F4 · derivative.exercise_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F4 · derivative.expiration_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
September 04, 2025 Filed Sep 8, 2025 22:28 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantDividend Equivalent Rights · Derivative 0.7138 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-028586 · rdgdoc.xml · derivative · entry 3

Ross Bridget A · CIK 0001698518 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5.3975

Underlying: Common Stock · 0.7138 shares

Expires not disclosed

F3 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F3 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F3 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
September 04, 2025 Filed Sep 8, 2025 22:28 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantDividend Equivalent Rights · Derivative 0.4173 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-028586 · rdgdoc.xml · derivative · entry 2

Ross Bridget A · CIK 0001698518 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5.5269

Underlying: Common Stock · 0.4173 shares

Expires not disclosed

F2 · derivative.exercise_price: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F2 · derivative.exercise_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F2 · derivative.expiration_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
September 04, 2025 Filed Sep 8, 2025 22:28 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantDividend Equivalent Rights · Derivative 0.4173 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-028586 · rdgdoc.xml · derivative · entry 1

Ross Bridget A · CIK 0001698518 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6.5156

Underlying: Common Stock · 0.4173 shares

Expires not disclosed

F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
August 08, 2025 Filed Aug 13, 2025 12:55 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 Exercise / conversionStock Option (Right to Buy) · Derivative 2,500 $0.00 Strike: $37.29 $0.00
Disclosure

SEC source: 0001437749-25-026366 · rdgdoc.xml · derivative · entry 3

Ross Bridget A · CIK 0001698518 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,500 shares

Expires 2025-12-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: This option is fully vested and exercisable.

Read SEC document
August 08, 2025 Filed Aug 13, 2025 12:55 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 SaleCommon Stock 2,500 $94.00 $235,000.00
Disclosure

SEC source: 0001437749-25-026366 · rdgdoc.xml · nonDerivative · entry 2

Ross Bridget A · CIK 0001698518 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,916

Read SEC document
August 08, 2025 Filed Aug 13, 2025 12:55 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 Exercise / conversionCommon Stock 2,500 $37.29 $93,225.00
Disclosure

SEC source: 0001437749-25-026366 · rdgdoc.xml · nonDerivative · entry 1

Ross Bridget A · CIK 0001698518 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,416

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II.

Read SEC document
May 29, 2025 Filed Jun 2, 2025 20:25 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantDividend Equivalent Rights · Derivative 1.0387 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-019168 · rdgdoc.xml · derivative · entry 5

Ross Bridget A · CIK 0001698518 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2.0397

Underlying: Common Stock · 1.0387 shares

Expires not disclosed

F5 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F5 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F5 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
May 29, 2025 Filed Jun 2, 2025 20:25 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantDividend Equivalent Rights · Derivative 1.0208 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-019168 · rdgdoc.xml · derivative · entry 4

Ross Bridget A · CIK 0001698518 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5.0145

Underlying: Common Stock · 1.0208 shares

Expires not disclosed

F4 · derivative.exercise_price: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F4 · derivative.exercise_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F4 · derivative.expiration_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
May 29, 2025 Filed Jun 2, 2025 20:25 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantDividend Equivalent Rights · Derivative 0.8524 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-019168 · rdgdoc.xml · derivative · entry 3

Ross Bridget A · CIK 0001698518 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4.6837

Underlying: Common Stock · 0.8524 shares

Expires not disclosed

F3 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F3 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F3 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
May 29, 2025 Filed Jun 2, 2025 20:25 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantDividend Equivalent Rights · Derivative 0.4985 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-019168 · rdgdoc.xml · derivative · entry 2

Ross Bridget A · CIK 0001698518 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5.1096

Underlying: Common Stock · 0.4985 shares

Expires not disclosed

F2 · derivative.exercise_price: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F2 · derivative.exercise_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F2 · derivative.expiration_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
May 29, 2025 Filed Jun 2, 2025 20:25 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantDividend Equivalent Rights · Derivative 0.4985 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-019168 · rdgdoc.xml · derivative · entry 1

Ross Bridget A · CIK 0001698518 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6.0983

Underlying: Common Stock · 0.4985 shares

Expires not disclosed

F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
May 12, 2025 Filed May 14, 2025 20:03 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 Exercise / conversionStock Option (Right to Buy) · Derivative 3,750 $0.00 Strike: $30.00 $0.00
Disclosure

SEC source: 0001437749-25-016827 · rdgdoc.xml · derivative · entry 3

Ross Bridget A · CIK 0001698518 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,750 shares

Expires 2025-04-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: This option is fully vested and exercisable.

Read SEC document
May 12, 2025 Filed May 14, 2025 20:03 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 SaleCommon Stock 3,750 $83.20 $312,000.00
Disclosure

SEC source: 0001437749-25-016827 · rdgdoc.xml · nonDerivative · entry 2

Ross Bridget A · CIK 0001698518 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,916

F2 · price: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $83.20 to $83.21. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.

Read SEC document
May 12, 2025 Filed May 14, 2025 20:03 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 Exercise / conversionCommon Stock 3,750 $30.00 $112,500.00
Disclosure

SEC source: 0001437749-25-016827 · rdgdoc.xml · nonDerivative · entry 1

Ross Bridget A · CIK 0001698518 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,666

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II.

Read SEC document
March 27, 2025 Filed Mar 31, 2025 21:30 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantDividend Equivalent Rights · Derivative 1.001 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-010297 · rdgdoc.xml · derivative · entry 5

Ross Bridget A · CIK 0001698518 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1.001

Underlying: Common Stock · 1.001 shares

Expires not disclosed

F5 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F5 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F5 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
March 27, 2025 Filed Mar 31, 2025 21:30 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantDividend Equivalent Rights · Derivative 0.9838 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-010297 · rdgdoc.xml · derivative · entry 4

Ross Bridget A · CIK 0001698518 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3.9937

Underlying: Common Stock · 0.9838 shares

Expires not disclosed

F4 · derivative.exercise_price: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F4 · derivative.exercise_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F4 · derivative.expiration_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
March 27, 2025 Filed Mar 31, 2025 21:30 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantDividend Equivalent Rights · Derivative 0.8214 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-010297 · rdgdoc.xml · derivative · entry 3

Ross Bridget A · CIK 0001698518 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3.8313

Underlying: Common Stock · 0.8214 shares

Expires not disclosed

F3 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F3 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F3 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
March 27, 2025 Filed Mar 31, 2025 21:30 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantDividend Equivalent Rights · Derivative 0.4803 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-010297 · rdgdoc.xml · derivative · entry 2

Ross Bridget A · CIK 0001698518 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4.6111

Underlying: Common Stock · 0.4803 shares

Expires not disclosed

F2 · derivative.exercise_price: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F2 · derivative.exercise_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F2 · derivative.expiration_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.